NF-κB activity is constitutively elevated in c-Abl null fibroblasts

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 42, 2009, Pages 17823-17828

  Liberatore, Rachel A ^a   Goff, Stephen P ^b   Nunes, Irene ^b,c  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Abelson kinase; Knockout mouse; Transcription regulation

Indexed keywords

ABELSON KINASE; DNA; HISTONE DEACETYLASE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; ENZYME INHIBITOR; HISTONE DEACETYLASE INHIBITOR; HYDROGEN PEROXIDE; HYDROXAMIC ACID; I KAPPA B; INTERLEUKIN 1BETA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; RELA PROTEIN, MOUSE; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BASAL CELL; CELL STIMULATION; CONTROLLED STUDY; DNA BINDING; EMBRYO CELL; ENZYME ACTIVITY; FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; WILD TYPE; ACTIVE TRANSPORT; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; ONCOGENE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

MUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; CELLS, CULTURED; DNA; ENZYME INHIBITORS; FIBROBLASTS; GENES, ABL; HISTONE DEACETYLASE INHIBITORS; HYDROGEN PEROXIDE; HYDROXAMIC ACIDS; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-ABL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449552859     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905935106     Document Type: Article

References (38)

1. Chen G, Goeddel DV (2002) TNF-R1 signaling: A beautiful pathway. Science 296(5573):1634-1635.
2. Haddad JJ (2002) Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 14(11):879-897. (Pubitemid 35247561)
3. Li X, Stark GR (2002) NFkappaB-dependent signaling pathways. Exp Hematol 30(4):285-296.
4. Martin MU, Wesche H (2002) Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 1592(3):265-280.
5. Bowie A, O'Neill LA (2000) Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59(1):13-23.
6. Hur GM, et al. (2003) The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev 17(7):873-882.
7. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl):S81-S96.
8. Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The IkappaB-NF-kappaB signaling module: Temporal control and selective gene activation. Science 298(5596):1241-1245. (Pubitemid 35285493)
9. Tian B, Brasier AR (2003) Identification of a nuclear factor kappa B-dependent gene network. Recent Prog Horm Res 58:95-130. (Pubitemid 37339306)
10. Perkins ND, et al. (1997) Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275(5299):523-527.
11. Gerritsen ME, et al. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94(7):2927-2932.
12. Sheppard KA, et al. (1999) Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 19(9):6367-6378.
13. Ashburner BP, Westerheide SD, Baldwin AS, Jr (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21(20):7065-7077.
14. Hoberg JE, Yeung F, Mayo MW (2004) SMRT derepression by the IkappaB kinase alpha: A prerequisite to NF-kappaB transcription and survival. Mol Cell 16(2):245-255. (Pubitemid 39388839)
15. Kiernan R, et al. (2003) Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278(4):2758-2766. (Pubitemid 36801357)
16. Dan S, et al. (1999) Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells. Oncogene 18(6):1277-1283. (Pubitemid 29094879)
17. Wang JY (2000) Regulation of cell death by the Abl tyrosine kinase. Oncogene 19(49):5643-5650.
18. Chau BN, Chen TT, Wan YY, DeGregori J, Wang JY (2004) Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation. Mol Cell Biol 24(10):4438-4447. (Pubitemid 41071013)
19. Klug CA, et al. (1994) The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes. Gene Dev 8(6):678-687.
20. Kawai H, Nie L, Yuan ZM (2002) Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl. Mol Cell Biol 22(17):6079-6088. (Pubitemid 34857828)
21. Cao C, Leng Y, Li C, Kufe D (2003) Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response. J Biol Chem 278(15):12961-12967. (Pubitemid 36800062)
22. Sun X, et al. (2000) Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J Biol Chem 275(23):17237-17240. (Pubitemid 30430754)
23. Haddad JJ (2002) Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NFkappaB nuclear translocation and activation. Biochem Biophys Res Commun 296(4):847-856.
24. Magness ST, et al. (2004) In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol 173(3):1561-1570.
25. Buchdunger E, et al. (1996) Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56(1):100-104. (Pubitemid 26011463)
26. Huang TT, Kudo N, Yoshida M, Miyamoto S (2000) A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci USA 97(3):1014-1019. (Pubitemid 30080804)
27. Huang TT, Miyamoto S (2001) Postrepression activation of NF-kappaB requires the aminoterminal nuclear export signal specific to IkappaBalpha. Mol Cell Biol 21(14):4737-4747.
28. Barila D, et al. (2003) Caspase-dependent cleavage of c-Abl contributes to apoptosis. Mol Cell Biol 23(8):2790-2799. (Pubitemid 36403078)
29. Perez P, Lira SA, Bravo R (1995) Overexpression of RelA in transgenic mouse thymocytes: Specific increase in levels of the inhibitor protein I kappa B alpha. Mol Cell Biol 15(7):3523-3530.
30. Sengupta N, Seto E (2004) Regulation of histone deacetylase activities. J Cell Biochem 93(1):57-67.
31. Agami R, Shaul Y (1998) The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes. Oncogene 16(14):1779-1788. (Pubitemid 28197398)
32. Xu Y, Sengupta PK, Seto E, Smith BD (2006) Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expression. J Biol Chem 281(14):9260-9270. (Pubitemid 43864641)
33. di Bari MG, et al. (2006) c-Abl acetylation by histone acetyltransferases regulates its nuclear-cytoplasmic localization. EMBO Rep 7(7):727-733.
34. Baskaran R, Dahmus ME, Wang JY (1993) Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc Natl Acad Sci USA 90(23):11167-11171. (Pubitemid 23354390)
35. Schwartzberg PL, et al. (1991) Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65(7):1165-1175.
36. Li B, et al. (2000) Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet 24(3):304-308. (Pubitemid 30132204)
37. Nunes I, Higgins RD, Zanetta L, Shamamian P, Goff SP (2001) c-abl is required for the development of hyperoxia-induced retinopathy. J Exp Med 193(12):1383-1391. (Pubitemid 32565967)
38. Hardin JD, Boast S, Mendelsohn M, de los Santos K, Goff SP (1996) Transgenes encoding both type I and type IV c-abl proteins rescue the lethality of c-abl mutant mice. Oncogene 12(12):2669-2677.